Michigan Risk Score for PICC-Related Thrombosis
The Michigan Risk Score predicts a patient’s likelihood of developing PICC‑associated thrombosis using five clinical and device-related risk factors 1.
使用適応
Used for adult inpatients receiving a new PICC to estimate early symptomatic PICC‑VTE risk and guide device choice or modifiable risk reduction (fewer lumens, delay placement if high WBC). Derived from 22 056 patients, identifying a 0.8% low‑risk vs 6.9% high‑risk VTE rate (OR 8.3) 1 [Level II evidence]. Most useful for avoiding high‑risk PICC placement and targeting closer monitoring.
洞察と注意事項
Start by recognizing that risk rises sharply with prior VTE, multilumen PICC, active cancer, concurrent central catheter, and WBC >12 000/µL, the five validated predictors from a 22 056‑patient cohort (PICCs→VTE 0.8% lowest‑ vs 6.9% highest‑risk; OR 8.3) 1 [Level II evidence].
Use cautiously: derived in Michigan hospitals only, limited external validation, and does not account for key modifiers (chemotherapy type, tip position, catheter‑to‑vein ratio) that strongly influence PICC thrombosis.